The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -69.41%. However, over the last six months, the performance has been stronger by -67.14%. The price of MYNZ decreased -20.96% over the last 30 days. And in the last five days, it has fallen by -17.04%.
Mainz Biomed N.V. saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $4.71 on 07/31/23, while the lowest price for the same duration was marked at $0.31 on 07/01/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of MYNZ Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Mainz Biomed N.V.’s current trading price is -92.46% away from its 52-week high, while its distance from the 52-week low is 12.67%. The stock’s price range during this period has varied between$0.31 and $4.71. The Mainz Biomed N.V.’s shares, which operate in the Healthcare, saw a trading volume of around 0.77 million for the day, a figure considerably higher than their average daily volume of 0.63 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Mainz Biomed N.V. (MYNZ) has experienced a quarterly decline of -59.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.77M.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7517, with a change in price of -0.5702. Similarly, Mainz Biomed N.V. recorded 425,035 in trading volume during the last 100 days, posting a change of -61.64%.
MYNZ’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MYNZ stands at 1.96. Similarly, the long-term debt-to-equity ratio is also 0.36.
MYNZ Stock Stochastic Average
Mainz Biomed N.V.’s raw stochastic average for the past 50 days is presently 5.74%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 16.29%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.69% and 21.27%, respectively.
